ExVilent is Drug Discovery in Canada that focus on drug discovery business. Founded in 2019. They cover business area such as operator, a biotechnology firm, system, pathophysiology modeling, drug discovery, humanize ex vivo lung model, decellularize murine lung scaffold, human cell, a condition, vivo environment, lung disease, particularly lung carcinoma, medical researcher, precision medicine, a low cost.
2019
( 5 years old in 2024 )
Drug Discovery
-
100 College Street
Suite 150
Toronto, Ontario M5G 1L5
Canada
Private
operatora biotechnology firmsystempathophysiology modelingdrug discoveryhumanize ex vivo lung modeldecellularize murine lung scaffoldhuman cella conditionvivo environmentlung diseaseparticularly lung carcinomamedical researcherprecision medicinea low cost
* We use standard office opening hours in near ExVilent's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ExVilent is Drug Discovery business from Canada that founded in 2019 (5 years old in 2024), ExVilent business is focusing on Drug Discovery.
ExVilent headquarter office and corporate office address is located in 100 College Street Suite 150 Toronto, Ontario M5G 1L5 Canada.
ExVilent was founded in Canada.
In 2024, ExVilent is currently focus on drug discovery sector.
Above is snippet of Google Trends for "drug discovery" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ExVilent, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.